3 documents found, page 1 of 1
Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum Di...
Apostolos-Pereira, Samira Luisa; Campos Ferreira, Lis; Boaventura, Mateus; de Carvalho Sousa, Nise Alessandra; Joca Martins, GabrielaMade available in DSpace on 2022-04-29T08:45:54Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-11-01; BACKGROUND AND OBJECTIVES: To describe the clinical features and disease outcomes of coronavirus disease 2019 (COVID-19) in patients with neuromyelitis optica spectrum disorder (NMOSD). METHODS: The Neuroimmunology Brazilian Study Group has set up the report of severe acute respiratory syndrome (SARS-Co...
Serological profile of John Cunningham virus (JCV) in patients with multiple sc...
Branco, Luciana Prats; Adoni, Tarso; Apostolos-Pereira, Samira Luisa; Brooks, Joseph Bruno Bidin; Correa, Eber Castro; Damasceno, Carlos AugustoAs opções terapêuticas para esclerose múltipla (EM) modificaram-se ao longo dos últimos anos, trazendo uma nova categoria de drogas com melhor perfil de eficácia. No entanto, estas drogas vieram com um novo perfil de potenciais eventos adversos que exigem que o neurologista os reconheça bem e rapidamente. Uma das complicações mais temidas destes tratamentos para a EM é a leucoencefalopatia multifocal progressiv...
Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy ...
Marques, Vanessa Daccach; Passos, Giordani Rodrigues dos; Mendes, Maria Fernando; Callegaro, Dagoberto; Lana-Peixoto, Marco AurelioMade available in DSpace on 2018-11-26T22:40:49Z (GMT). No. of bitstreams: 0 Previous issue date: 2018-08-01. Added 1 bitstream(s) on 2019-10-09T18:27:56Z : No. of bitstreams: 1 S0004-282X2018000800539.pdf: 336862 bytes, checksum: 861f2018734ed5dc938f69878cf50b6e (MD5); Biogen Idec; Genzyme; Merck; Novartis; Rocha; Teva; Roche; Sanofi-Genzyme; World Federation of Neurology; European Committee on Treatment and R...